- Report
- January 2023
- 229 Pages
Middle East, Africa
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- August 2022
- 120 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- November 2018
- 164 Pages
Global
From €10612EUR$10,995USD£9,103GBP
Coartem is a brand of antimalarial drug used to treat and prevent malaria. It is a combination of artemether and lumefantrine, two active ingredients that work together to kill the malaria parasites in the blood. Coartem is used to treat uncomplicated Plasmodium falciparum malaria, the most severe form of malaria. It is also used to prevent malaria in people who are travelling to areas where malaria is common. Coartem is an important drug in the treatment of infectious diseases, as it is effective against a wide range of parasites.
Coartem is manufactured by Novartis, a Swiss pharmaceutical company. Other companies that produce antimalarial drugs include GlaxoSmithKline, Sanofi, and Cipla. These companies produce a variety of antimalarial drugs, including artemisinin-based combination therapies, artemisinin monotherapies, and other antimalarial drugs. Show Less Read more